People · Operator
Named in public records as an officer, director or promoter · active 2013–2019 · Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LucidWorks, Inc. | — | Other Technology | Series B | $71.7M | $700.5M | 2013 |
| Integrated Oncology Network Holdco, LLC | — | Pharma | Series C | $69.9M | $2.5B | 2019 |
Grant Ingersoll at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Grant Ingersoll on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ravi Mohan | 1 | 14 |
| Spencer Tall | 1 | 12 |
| Andrew Kau | 1 | 8 |
| Mary Coleman | 1 | 6 |
| Mark Brewer | 1 | 3 |
| Chris McKay | 1 | 3 |
| Daniel Gill | 1 | 3 |
| Reade Frank | 1 | 2 |
| Barry Tanner | 1 | 2 |
| Paul Doscher | 1 | 2 |
| Marc Krellenstein | 1 | 1 |
| Wade Glisson | 1 | 1 |
| Eric Gries | 1 | 1 |
| Frank Calderon | 1 | 1 |
| Michael Moody | 1 | 1 |
| Will Hayes | 1 | 1 |
| Carol Lopez | 1 | 1 |
| Jeffrey Goffman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.